Our observation of a positive correlation between COX-2 and tumor stage and/or grading goes along with the results by Sheehan et al. [74] in colon cancer, Miyata et al. [75] in renal cell carcinoma, and Boland et al. [59] in DCIS of breast. The gene discussed is PTGS2; the disease is ductal breast carcinoma in situ.